164 related articles for article (PubMed ID: 24615628)
1. Oxaliplatin-induced renal tubular vacuolization.
Joybari AY; Sarbaz S; Azadeh P; Mirafsharieh SA; Rahbari A; Farasatinasab M; Mokhtari M
Ann Pharmacother; 2014 Jun; 48(6):796-800. PubMed ID: 24615628
[TBL] [Abstract][Full Text] [Related]
2. A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia.
Yamada S; Yazawa M; Yamamoto M; Koitabashi K; Ichikawa D; Koike J; Shibagaki Y
CEN Case Rep; 2019 Aug; 8(3):188-193. PubMed ID: 30827015
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
4. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.
Ito I; Ito Y; Mizuno M; Suzuki Y; Yasuda K; Ozaki T; Kosugi T; Yasuda Y; Sato W; Tsuboi N; Maruyama S; Imai E; Matsuo S
Clin Exp Nephrol; 2012 Jun; 16(3):490-4. PubMed ID: 22450906
[TBL] [Abstract][Full Text] [Related]
5. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
[TBL] [Abstract][Full Text] [Related]
6. Acute immune hematological complication of oxaliplatin. A series of 3 cases.
Garciaz S; Oziel-Taieb S; Dermeche S; Ries P; Vessaud J; Raoul JL
Tumori; 2014; 100(1):e17-9. PubMed ID: 24675502
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin-induced proximal renal tubular acidosis.
Negro A; Grasselli C; Galli P
Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
[No Abstract] [Full Text] [Related]
8. Oxaliplatin-induced acute tubulointerstitial nephritis: Two case reports
.
Choi YJ; Oh KH; Kang HR; Lee SJ
Clin Nephrol; 2018 Feb; 89(2):130-134. PubMed ID: 29231160
[TBL] [Abstract][Full Text] [Related]
9. Disseminated intravascular coagulation and immune hemolytic anemia, possibly Evans syndrome, after oxaliplatin and bevacizumab infusion for metastatic colon adenocarcinoma: a case report and literature review.
Meng L; Romano A; Smith E; Macik G; Grosh WW
Clin Colorectal Cancer; 2015 Mar; 14(1):e1-3. PubMed ID: 25600448
[No Abstract] [Full Text] [Related]
10. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
11. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
Sonnenblick A; Meirovitz A
Int J Clin Oncol; 2010 Aug; 15(4):420-2. PubMed ID: 20217448
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
13. A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
Curtis SA; Curtis BR; Lee AI; Hendrickson JE; Lacy J; Podoltsev NA
Hematology; 2018 Aug; 23(7):429-432. PubMed ID: 29281948
[TBL] [Abstract][Full Text] [Related]
14. Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.
Baretta Z; Falci C; Piva E; Conte P
Clin Colorectal Cancer; 2013 Dec; 12(4):294-6. PubMed ID: 24188688
[No Abstract] [Full Text] [Related]
15. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
16. [Recurrent autoimmune hemolytic anemia induced by XELOX chemotherapy for colon cancer].
Ogura T; Tajika M; Niwa Y; Kawai H; Kondo S; Sawaki A; Mizuno N; Hara K; Hijioka S; Nakamura M; Higuchi K; Goto H; Yamao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1712-9. PubMed ID: 21971145
[TBL] [Abstract][Full Text] [Related]
17. [Immune-mediated hemolytic anemia under oxaliplatin].
Gundling F; Tiller M; Fuchs M; Schepp W
Z Gastroenterol; 2008 Jul; 46(7):695-9. PubMed ID: 18618381
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
[TBL] [Abstract][Full Text] [Related]
19. Histopathological and biochemical assessment of kidney damage in albino wistar rats treated with cytotoxic platinum compounds in combination with 5-FU.
Bano N; Ikram R
Pak J Pharm Sci; 2017 Sep; 30(5):1595-1601. PubMed ID: 29084678
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review.
Forcello NP; Khubchandani S; Patel SJ; Brahaj D
J Oncol Pharm Pract; 2015 Apr; 21(2):148-56. PubMed ID: 24500808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
